Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
4,347
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study

Kenji Morimotoa Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanORCID Iconhttps://orcid.org/0000-0003-3394-1838View further author information
ORCID Icon,
Junji Uchinoa Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0651-7767View further author information
ORCID Icon,
Takashi Yokoib Department of Thoracic Oncology, Hyogo College of Medicine, Hyogo, JapanORCID Iconhttps://orcid.org/0000-0002-1600-8950View further author information
ORCID Icon,
Takashi Kijimab Department of Thoracic Oncology, Hyogo College of Medicine, Hyogo, JapanORCID Iconhttps://orcid.org/0000-0003-4249-4021View further author information
ORCID Icon,
Yasuhiro Gotoc Department of Respiratory Medicine, Fujita Health University, Aichi, JapanView further author information
,
Akira Nakaod Department of Respiratory Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, JapanView further author information
,
Makoto Hibinoe Department of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Kanagawa, JapanView further author information
,
Takayuki Takedaf Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto, JapanORCID Iconhttps://orcid.org/0000-0002-8375-6940View further author information
ORCID Icon,
Hiroyuki Yamaguchig Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanView further author information
,
Chieko Takumih Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, JapanView further author information
,
Masafumi Takeshitai Department of Respiratory Medicine, Ichinomiyanishi Hospital, Aichi, JapanView further author information
,
Yusuke Chiharaj Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Kyoto, JapanView further author information
,
Takahiro Yamadak Department of Pulmonary Medicine, Matsushita Memorial Hospital, Osaka, JapanView further author information
,
Osamu Hiranumal Department of Pulmonary Medicine, Otsu City Hospital, Shiga, JapanView further author information
,
Yoshie Morimotoa Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanView further author information
,
Masahiro Iwasakua Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanView further author information
,
Yoshiko Kanekoa Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanView further author information
,
Tadaaki Yamadaa Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanORCID Iconhttps://orcid.org/0000-0002-6945-281XView further author information
ORCID Icon &
Koichi Takayamaa Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanView further author information
 show all
Article: 1950411 | Received 07 Apr 2021, Accepted 26 Jun 2021, Published online: 08 Jul 2021

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mahmathi Karuppannan, Fares M. S. Muthanna & Fazlin Mohd Fauzi. (2024) Breaking Down Cachexia: A Narrative Review on the Prevalence of Cachexia in Cancer Patients and Its Associated Risk Factors. Nutrition and Cancer 76:5, pages 404-418.
Read now
Vanessa C Vaughan & Peter Martin. (2022) Multidisciplinary approaches to cancer cachexia: current service models and future perspectives. Expert Review of Anticancer Therapy 22:7, pages 737-749.
Read now

Articles from other publishers (16)

Haoqian Li, Butuo Li, Xiaoqing Wang, Huan Zhang, Chunni Wang, Bingjie Fan & Linlin Wang. (2024) Effect of longitudinal changes of cachexia on the efficacy and toxicity of immune checkpoint inhibitors in esophageal squamous cell cancer (ESCC) patients. Nutrition 124, pages 112462.
Crossref
Philip D. Bonomi, Jeffrey Crawford, Richard F. Dunne, Eric J. Roeland, Karen E. Smoyer, Mohd Kashif Siddiqui, Thomas D. McRae, Michelle I. Rossulek, James H. Revkin & Lisa C. Tarasenko. (2024) Mortality burden of pre‐treatment weight loss in patients with non‐small‐cell lung cancer: A systematic literature review and meta‐analysis. Journal of Cachexia, Sarcopenia and Muscle.
Crossref
Yean Yu, Li Yan, Tianhui Huang, Zhenfu Wu & Juan Liu. (2024) Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients. Aging 16:6, pages 5354-5369.
Crossref
Valentina Bartolomeo, Mandy Jongbloed, Wouter R. P. H. van de Worp, Ramon Langen, Juliette Degens, Lizza E. L. Hendriks & Dirk K. M. de Ruysscher. (2024) Cachexia and Sarcopenia in Oligometastatic Non-Small Cell Lung Cancer: Making a Potential Curable Disease Incurable?. Cancers 16:1, pages 230.
Crossref
Yoshiko Ishioka, Hisashi Tanaka, Tomonori Makiguchi, Syunsuke Fujishima, Yasuhito Nunomura, Hiroaki Sakamoto, Toshihiro Shiratori, Kageaki Taima & Sadatomo Tasaka. (2023) Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study. Oncology Letters 27:1.
Crossref
Jingxiao Jin, Jacqueline Visina, Timothy F. Burns, Brenda Diergaarde & Laura P. Stabile. (2023) Male sex and pretreatment weight loss are associated with poor outcome in patients with advanced non-small cell lung cancer treated with immunotherapy: a retrospective study. Scientific Reports 13:1.
Crossref
Keiko Tanimura, Takayuki Takeda, Akihiro Yoshimura, Ryoichi Honda, Shiho Goda, Shinsuke Shiotsu, Mototaka Fukui, Yusuke Chihara, Kiyoaki Uryu, Shota Takei, Yuki Katayama, Makoto Hibino, Tadaaki Yamada & Koichi Takayama. (2023) Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study. Cancers 15:17, pages 4358.
Crossref
Kenji Morimoto, Tadaaki Yamada, Takayuki Takeda, Shinsuke Shiotsu, Koji Date, Taishi Harada, Nobuyo Tamiya, Yusuke Chihara, Yoshizumi Takemura, Takahiro Yamada, Hibiki Kanda, Masaki Ishida, Akihiro Yoshimura, Masahiro Iwasaku, Shinsaku Tokuda, Young Hak Kim & Koichi Takayama. (2023) Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum–Etoposide Chemotherapy. Drugs & Aging 40:6, pages 563-571.
Crossref
Shiting Xu, Keita Miura, Takehito Shukuya, Sonoko Harada, Masahiro Fujioka, Wira Winardi, Shoko Shimamura, Kana Kurokawa, Issei Sumiyoshi, Taichi Miyawaki, Tetsuhiko Asao, Yoichiro Mitsuishi, Ken Tajima, Fumiyuki Takahashi, Takuo Hayashi, Norihiro Harada & Kazuhisa Takahashi. (2023) Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines. Cancers 15:4, pages 1170.
Crossref
Clelia Madeddu, Silvia Busquets, Clelia Donisi, Eleonora Lai, Andrea Pretta, Francisco Javier López-Soriano, Josep Maria Argilés, Mario Scartozzi & Antonio Macciò. (2023) Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer. Cancers 15:4, pages 1076.
Crossref
Koichi Takayama, Toru Takiguchi, Naoyuki Komura & Tateaki Naito. (2022) Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study. Cancer Medicine 12:3, pages 2918-2928.
Crossref
Maurizio Muscaritoli, Gil Bar-Sela, Nicolo Matteo Luca Battisti, Borislav Belev, Jorge Contreras-Martínez, Enrico Cortesi, Ione de Brito-Ashurst, Carla M. Prado, Paula Ravasco & Suayib Yalcin. (2023) Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO). Cancers 15:2, pages 380.
Crossref
Taiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, Yusuke Okuma, Shohei Nakamura, Danielle Moreau-Amaru, Taichi Tamura, Yukio Hosomi, Haruko Takeyama, Corentin Richard, Masahito Hosokawa & Bertrand Routy. (2022) Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis. Cancers 14:21, pages 5405.
Crossref
Kenji Morimoto, Tadaaki Yamada, Takayuki Takeda, Shinsuke Shiotsu, Koji Date, Taishi Harada, Nobuyo Tamiya, Yusuke Chihara, Osamu Hiranuma, Takahiro Yamada, Hibiki Kanda, Takayuki Nakano, Yoshie Morimoto, Masahiro Iwasaku, Shinsaku Tokuda & Koichi Takayama. (2022) Efficacy and Safety of Programmed Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC: A Prospective Observational Study. JTO Clinical and Research Reports 3:7, pages 100353.
Crossref
Yizhen Guo, Lai Wei, Sandip H. Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li, Tyler Haddad, Andrew Johns, Latha P. Ganesan, Yiping Yang, Daniel J. Spakowicz, Peter G. Shields, Kai He, Erin M. Bertino, Gregory A. Otterson, David P. Carbone, Carolyn Presley, Samuel K. Kulp, Thomas A. Mace, Christopher C. Coss, Mitch A. Phelps & Dwight H. Owen. (2022) Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy. Clinical Lung Cancer 23:4, pages 345-355.
Crossref
Taisuke Araki, Yoshiaki Kitaguchi, Yusuke Suzuki, Masamichi Komatsu, Kei Sonehara, Yosuke Wada, Kazunari Tateishi & Masayuki Hanaoka. (2021) Prognostic implication of erector spinae muscles in non‐small‐cell lung cancer patients treated with immuno‐oncology combinatorial chemotherapy. Thoracic Cancer 12:21, pages 2857-2864.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.